Another attractive approach in the treatment of gliomas is the use of siRNA, short interfering double-stranded RNA molecules that are potentially capable of specifically inhibiting signaling pathways associated with the development and progression of glioblastomas, for example, the EGFR and b-catenin genes [53]. Here, EGFR is linked to central nervous system cancer.